Therapy with semaglutide (Ozempic or Wegovy) and tirzepatide (Mounjaro) in the context of obesity - Update 2025
Introduction Obesity is one of the greatest health challenges of our time. According to the Robert Koch Institute (RKI), over 50% of adults in Germany are overweight, of which around 23% are obese (BMI ≥ 30 ... Read more